Investors Research Corp Actinium Pharmaceuticals, Inc. Transaction History
Investors Research Corp
- $448 Million
- Q1 2025
A detailed history of Investors Research Corp transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Investors Research Corp holds 250 shares of ATNM stock, worth $357. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250Holding current value
$357% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
74Shares Held
8.66MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.68 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$2.25 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$1.02 Million0.0% of portfolio
-
State Street Corp Boston, MA621KShares$888,1370.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$713,9410.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $36M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...